News | July 03, 2012

Arterial Ultrasound Useful for Determining Sub-clinical Atherosclerosis in Young People with Diabetes, Obesity


July 3, 2012 — Despite the rising incidence of peripheral arterial disease (PAD), there has been little data available on the prevalence and clinical correlates of sub-clinical atherosclerosis in the peripheral arteries in large population-based samples. Researchers at NewYork-Presbyterian/Weill Cornell Medical Center, led by primary investigator Dr. Ingrid Hriljac, have addressed this gap by performing ultrasound exams of the popliteal (behind the knee) and carotid arteries in the fifth examination of the Strong Heart Study (SHS), which included 3,240 members of 65 multi-generation families. The Strong Heart Study (SHS) is an epidemiologic survey of cardiovascular risk factors and disease in 13 native American tribes in three regions, with initial exam of 4,549 participants from 1989 to 1992.

A poster based on the study, which looked for the presence and degree of popliteal arterial plaque as a predictor of atherosclerosis throughout the arteries of the body. This poster will be presented on Sunday, July 1 from 9:30 a.m. to 4:30 p.m. in the exhibit and poster hall during the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions. Investigators will be available in the hall from 12:15 p.m. to 1:45 p.m. The ASE Scientific Sessions will be held from June 27 through July 3, 2012, at the Gaylord National in National Harbor, MD.

According to Dr. Hriljac, researchers found that in a young population (<40 years old) with high prevalence of obesity and diabetes, popliteal artery atherosclerosis is prevalent and independently associated with older age and greater leakage of albumin in the urine (known as albuminuria) — a known marker of end organ damage in diabetes. This study was able to provide a link between urinary albuminuria and severity of atherosclerotic plaque burden in the popliteal arteries. These findings also support albuminuria as a marker of disease of large lower extremity arteries as well as of small vessel disease in young individuals with type 2 diabetes.


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now